López-Carriches C, Taheri R, Madrigal-Martínez-Pereda C. Clinical study on hemorrhagic complications in antiplatelet and anticoagulated patients undergoing dental treatment. Med Oral Patol Oral Cir Bucal. 2026 Mar 1;31 (2):e219-23.

doi:10.4317/medoral.27715

https://dx.doi.org/doi:10.4317/medoral.27715


1. Castilla-Guerra L, Fernández-Moreno MDC, de la Vega-Sánchez JM, León Jiménez D. Bleeding risk assessment for stroke patients on antithrombotic therapy. Clin Investig Arterioscler. 2019;31(6):282-8.
https://doi.org/10.1016/j.artere.2019.11.003
PMid:31005341

 

2. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093-100.
https://doi.org/10.1378/chest.10-0134
PMid:20299623

 

3. Brennan MT, Wynn RL, Miller CS. Aspirin and bleeding in dentistry: an update and recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104(3):316-23.
https://doi.org/10.1016/j.tripleo.2007.03.003
PMid:17618144

 

4. Napeñas JJ, Hong CH, Brennan MT, Furney SL, Fox PC, Lockhart PB. The frequency of bleeding complications after invasive dental treatment in patients receiving single and dual antiplatelet therapy. J Am Dent Assoc. 2009;140(6):690-5.
https://doi.org/10.14219/jada.archive.2009.0255
PMid:19491165

 

5. Sánchez-Palomino P, Sánchez-Cobo P, Rodriguez-Archilla A, González-Jaranay M, Moreu G, Calvo-Guirado JL, et al. Dental extraction in patients receiving dual antiplatelet therapy. Med Oral Patol Oral Cir Bucal. 2015;20(5):e616-20.
https://doi.org/10.4317/medoral.20510
PMid:26241454 PMCid:PMC4598932

 

6. Lillis T, Ziakas A, Koskinas K, Tsirlis A, Giannoglou G. Safety of dental extractions during uninterrupted single or dual antiplatelet treatment. Am J Cardiol. 2011;108(7):964-7.
https://doi.org/10.1016/j.amjcard.2011.05.029
PMid:21784392

 

7. Lu SY, Tsai CY, Lin LH, Lu SN. Dental extraction without stopping single or dual antiplatelet therapy: results of a retrospective cohort study. Int J Oral Maxillofac Surg. 2016;45(10):1293-8.
https://doi.org/10.1016/j.ijom.2016.02.010
PMid:26972159

 

8. Kämmerer PW, Frerich B, Liese J, Schiegnitz E, Al-Nawas B. Oral surgery during therapy with anticoagulants: a systematic review. Clin Oral Investig. 2015;19(2):171-80.
https://doi.org/10.1007/s00784-014-1366-3
PMid:25413495

 

9. Miclotte I, Vanhaverbeke M, Agbaje JO, Legrand P, Vanassche T, Verhamme P, et al. Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: a prospective case-control study. Clin Oral Investig. 2017;21(7):2183-8.
https://doi.org/10.1007/s00784-016-2010-1
PMid:27891570

 

10. Curto A, Albaladejo A, Alvarado A. Dental management of patients taking novel oral anticoagulants (NOAs): dabigatran. J Clin Exp Dent. 2017;9(2):e289-93.
https://doi.org/10.4317/jced.53219
PMid:28210451 PMCid:PMC5303333

 

11. Breik O, Cheng A, Sambrook P, Goss A. Protocol in managing oral surgical patients taking dabigatran. Aust Dent J. 2014;59(3):296-301.
https://doi.org/10.1111/adj.12199
PMid:24889878

 

12. Hanken H, Gröbe A, Heiland M, Smeets R, Kluwe L, Wikner J, et al. Postoperative bleeding risk for oral surgery under continued rivaroxaban anticoagulant therapy. Clin Oral Investig. 2016;20(6):1279-82.
https://doi.org/10.1007/s00784-015-1627-9
PMid:26498769

 

13. López-Galindo M, Bagán JV. Apixaban and oral implications. J Clin Exp Dent. 2015;7(4):e528-34.
https://doi.org/10.4317/jced.52470
PMid:26535102 PMCid:PMC4628810

 

14. Curto A, Curto D, Sanchez J. Managing patients taking edoxaban in dentistry. J Clin Exp Dent. 2017;9(2):e308-11.
https://doi.org/10.4317/jced.53431
PMid:28210454 PMCid:PMC5303336

 

15. Spyropoulos AC, Al-Badri A, Sherwood MW, Douketis JD. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. J Thromb Haemost. 2016;14(5):875-85.
https://doi.org/10.1111/jth.13305
PMid:26988871

 

16. Manfredi M, Dave B, Percudani D, Christoforou J, Karasneh J, Diz Dios P, et al. World workshop on oral medicine VII: direct anticoagulant agents management for invasive oral procedures: a systematic review and meta-analysis. Oral Dis. 2019;25(Suppl 1):157-73.
https://doi.org/10.1111/odi.13086
PMid:31140701

 

17. Izzetti R, Cinquini C, Nisi M, Mattiozzi M, Marotta M, Barone A. Direct oral anticoagulants and bleeding management following tooth extractions: a prospective cohort study. Dent J (Basel). 2024;12(9):279.
https://doi.org/10.3390/dj12090279
PMid:39329845 PMCid:PMC11430983

 

18. Johnston S. An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery. Int J Oral Maxillofac Surg. 2016;45(5):618-30.
https://doi.org/10.1016/j.ijom.2015.12.010
PMid:26774397

 

19. Abayon M, Kolokythas A, Harrison S, Elad S. Dental management of patients on direct oral anticoagulants: case series and literature review. Quintessence Int. 2016;47(8):687-96.
https://doi.org/10.3290/j.qi.a36325
PMid:27574712

 

20. Lupi SM, Rodriguez Y Baena A. Patients taking direct oral anticoagulants (DOAC) undergoing oral surgery: a review of the literature and a proposal of a peri-operative management protocol. Healthcare (Basel). 2020;8(3):281.
https://doi.org/10.3390/healthcare8030281
PMid:32825272 PMCid:PMC7551164

 

21. Engelen ET, Schutgens RE, Mauser-Bunschoten EP, van Es RJ, van Galen KP. Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions. Cochrane Database Syst Rev. 2018;7(7):CD012293.
https://doi.org/10.1002/14651858.CD012293.pub2
PMid:29963686 PMCid:PMC6513563

 

22. Queiroz SI, Alves HS, de Assis GM, Conceicao TS, Germano AR, da Silva JS. An evaluation of the efficacy of local hemostatic measures in dental patients taking oral anticoagulants: a critical review of the literature over the past two decades. Curr Clin Pharmacol. 2016;11(4):230-40.
https://doi.org/10.2174/1574884711666161003163217
PMid:27697071

 

23. Levy JH, Douketis J, Weitz JI. Reversal agents for non-vitamin K antagonist oral anticoagulants. Nat Rev Cardiol. 2018;15(5):273-81.
https://doi.org/10.1038/nrcardio.2017.223
PMid:29345686

 

24. Crowther M, Cuker A. How can we reverse bleeding in patients on direct oral anticoagulants? Kardiol Pol. 2019;77(1):3-11.
https://doi.org/10.5603/KP.a2018.0197
PMid:30338501